![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 48 Subgroup Analysis
|
|
|
Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
J Feinberg,1 JP Lalezari,2 M Martins,3 M Casapia,4 D Stock,5 C Llamoso,5 SR Joshi,5 GJ Hanna,6 M Lataillade 5 for the AI438011 study team
1University of Cincinnati, Cincinnati, OH, USA; 2. Quest Clinical Research, San Francisco, CA, USA; 3. Instituto Oulton, Cordoba, Argentina; 4. Asociacion Civil Selva Amazonica, Iquitos, Peru; 5. Bristol-Myers Squibb, Wallingford, CT, USA; 6. Bristol-Myers Squibb, Princeton, NJ, USA.
![IDSA1.gif](../images/101415/101415-11/IDSA1.gif)
![IDSA2.gif](../images/101415/101415-11/IDSA2.gif)
![IDSA3.gif](../images/101415/101415-11/IDSA3.gif)
![IDSA4.gif](../images/101415/101415-11/IDSA4.gif)
![IDSA5.gif](../images/101415/101415-11/IDSA5.gif)
![IDSA6.gif](../images/101415/101415-11/IDSA6.gif)
![IDSA7.gif](../images/101415/101415-11/IDSA7.gif)
![IDSA8.gif](../images/101415/101415-11/IDSA8.gif)
![IDSA9.gif](../images/101415/101415-11/IDSA9.gif)
![IDSA10.gif](../images/101415/101415-11/IDSA10.gif)
![IDSA11.gif](../images/101415/101415-11/IDSA11.gif)
![IDSA12.gif](../images/101415/101415-11/IDSA12.gif)
![IDSA13.gif](../images/101415/101415-11/IDSA13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|